These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 26520433)
1. A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders. Gendelman HE; Mosley RL J Neuroimmune Pharmacol; 2015 Dec; 10(4):645-50. PubMed ID: 26520433 [TBL] [Abstract][Full Text] [Related]
2. Innate Immunity and Neurodegeneration. Labzin LI; Heneka MT; Latz E Annu Rev Med; 2018 Jan; 69():437-449. PubMed ID: 29106805 [TBL] [Abstract][Full Text] [Related]
3. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Machhi J; Kevadiya BD; Muhammad IK; Herskovitz J; Olson KE; Mosley RL; Gendelman HE Mol Neurodegener; 2020 Jun; 15(1):32. PubMed ID: 32503641 [TBL] [Abstract][Full Text] [Related]
4. Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases. Lindestam Arlehamn CS; Garretti F; Sulzer D; Sette A Curr Opin Immunol; 2019 Aug; 59():115-120. PubMed ID: 31430650 [TBL] [Abstract][Full Text] [Related]
5. Inflammation and adaptive immunity in Parkinson's disease. Mosley RL; Hutter-Saunders JA; Stone DK; Gendelman HE Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a009381. PubMed ID: 22315722 [TBL] [Abstract][Full Text] [Related]
6. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482 [TBL] [Abstract][Full Text] [Related]
7. [Research Progress of CD4 Chen WY; Qian Y; Chen TY; Gu XP Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Aug; 43(4):628-633. PubMed ID: 34494536 [TBL] [Abstract][Full Text] [Related]
8. Nutrition, Immunity and Aging: Current Scenario and Future Perspectives in Neurodegenerative Diseases. Barbero Mazzucca C; Cappellano G; Chiocchetti A CNS Neurol Disord Drug Targets; 2024; 23(5):573-587. PubMed ID: 37138438 [TBL] [Abstract][Full Text] [Related]
9. Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation. Sta M; Sylva-Steenland RM; Casula M; de Jong JM; Troost D; Aronica E; Baas F Neurobiol Dis; 2011 Jun; 42(3):211-20. PubMed ID: 21220013 [TBL] [Abstract][Full Text] [Related]
10. Periphery and brain, innate and adaptive immunity in Parkinson's disease. Harms AS; Ferreira SA; Romero-Ramos M Acta Neuropathol; 2021 Apr; 141(4):527-545. PubMed ID: 33555429 [TBL] [Abstract][Full Text] [Related]
11. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? Appel SH; Beers DR; Henkel JS Trends Immunol; 2010 Jan; 31(1):7-17. PubMed ID: 19879804 [TBL] [Abstract][Full Text] [Related]
12. Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases. Dhib-Jalbut S; Arnold DL; Cleveland DW; Fisher M; Friedlander RM; Mouradian MM; Przedborski S; Trapp BD; Wyss-Coray T; Yong VW J Neuroimmunol; 2006 Jul; 176(1-2):198-215. PubMed ID: 16983747 [TBL] [Abstract][Full Text] [Related]
13. Innate and adaptive immune responses in Parkinson's disease. Schonhoff AM; Williams GP; Wallen ZD; Standaert DG; Harms AS Prog Brain Res; 2020; 252():169-216. PubMed ID: 32247364 [TBL] [Abstract][Full Text] [Related]
14. Compromised MAPK signaling in human diseases: an update. Kim EK; Choi EJ Arch Toxicol; 2015 Jun; 89(6):867-82. PubMed ID: 25690731 [TBL] [Abstract][Full Text] [Related]